| Structure | Chemical Name | CAS | MF |
|
Ceftriaxone sodium crystalline.sterile
|
|
|
|
|
Ceftriaxone sodium (solvent crystallization of sterile BPC) CHP 、USP、EP 5kg/tin、2tin/box
|
|
|
|
|
Ceftriazone sodium sterile IP/Bp
|
|
|
|
|
CEFTRIAXONE(SUBJECTTOPATENTFREE)
|
|
|
|
|
Ceftriaxone sodium (crude) In-house Spec 25kg/box
|
|
|
|
Ceftriaxone sodium
|
104376-79-6
|
C18H21N8NaO8S3
|
|
|
CD45RB,CLONE:16A,RATMABANTI-MOUSE,PE
|
|
|
|
|
CD45RB,CLONE:16A,RATMABANTI-MOUSE,AZIDE-FREE
|
|
|
|
|
CDR3.AME(82-89)
|
|
|
|
|
CD45RB,CLONE:16A,RATMABANTI-MOUSE,BIOTIN
|
|
|
|
|
CD45RB,CLONE:MEM55,MABANTI-HUMAN:FROZEN/PARAFFIN,IH/NOWB
|
|
|
|
|
CD45RB,CLONE:16A,RATMABANTI-MOUSE,FITC
|
|
|
|
|
CD45RB,CLONE:16A,RATMABANTI-MOUSE
|
|
|
|
|
CD45RA,MABANTI-
|
|
|
|
|
CD45RB,CLONE:16A,RATMABANTI-MOUSE,PE-CY5
|
|
|
|
|
CDP tyvelose-2-epimerase
|
|
|
|
|
CdrA protein
|
|
|
|
Δ2-Cefuroxime Axetil
|
123458-61-7
|
C20H22N4O10S
|
|
Δ2-Cefuroxime
|
229499-08-5
|
C16H16N4O8S
|
|
CefuroxiMe Axetil-d3
|
|
C20H22N4O10S
|
|
|
Cefuroxime(acid,axetil,sodium)
|
|
|
|
|
cefuroxime axetil esterase
|
|
|
|
cefuracetime
|
39685-31-9
|
C17H17N3O8S
|
|
|
CEFUROXIME FREE ACID
|
555268-75-2
|
|
|
|
Cefuroxime Acid / for Cefuroxime Sodium or Axetil
|
|
|
|
|
Cefuroxime axetil,Crystalline
|
|
|
|
|
Cefuroxime Axetil Amorphous/Crystalline
|
|
|
|
|
Cefuroxime Axetil amorphous Form
|
|
|
|
Cefuroxime
|
55268-75-2
|
C16H16N4O8S
|
|
Cefuroxime 1-acetoxyethyl ester
|
64544-07-6
|
C20H22N4O10S
|
|
Cefuroxime sodium
|
56238-63-2
|
C16H15N4O8S.Na
|
|
|
CEFUROXIME ACID
|
|
|
|
Cefuroxime-d3
|
|
C16H16N4O8S
|
|
|
CD23-PURIFIED,MABANTI-HUMAN,CLONE:1B12
|
|
|
|
|
CD15-PURO,MABANTI-HUMAN,CLONE:MCS-1
|
|
|
|
|
CD10-PURIFIED,MABANTI-HUMAN,CLONE:B-E3
|
|
|
|
|
CD20-PURIFIED,MABANTI-HUMAN,CLONE:B9E9
|
|
|
|
|
CD22-PURIFIED,MABANTI-HUMAN,CLONE:MC64-12
|
|
|
|
|
CD138-PURIFIED,MABANTI-HUMAN,CLONE:B-B4
|
|
|
|
|
CD19-PURIFIED,MABANTI-HUMAN,CLONE:A3/B1
|
|
|
|
|
CD38-PURIFIED,MABANTI-HUMAN,CLONE:LD38
|
|
|
|
CEFUROXIME SODIUM
|
|
C16H16N4NaO8S
|
|
|
CefuromeAxetil
|
|
|
|
|
CefuroximeAxetilTablets
|
|
|
|
|
Cefuroxime axetil oral
|
|
|
|
cefuroxime lysine
|
65527-51-7
|
|
|
|
CefuroximeInjection
|
|
|
|
|
Cefuroxime Sodium,Non-sterile
|
|
|
|
|
CD226,RATMABANTI-MOUSE:CLONE:15F.10E5,RATIGMK,FITC
|
|
|
|
|
CD157,RATMABANTI-MOUSE:CLONE:KT157,PE
|
|
|
|
|
Cd61,Rat
|
|
|
|
|
CD80,RATANTI-MOUSE
|
|
|
|
|
CD94,RATMABANTI-MOUSE:CLONE:15F.18D1,RATIGG1K,PE
|
|
|
|
|
CD5,RATMABANTI-MOUSE:CLONE:53-7.8,RATIGG2A
|
|
|
|
|
CD2, Rat Mab anti-Mouse
|
|
|
|
|
CD2, Rat Mab anti-Mouse, FITC
|
|
|
|
|
CD2, Rat Mab anti-Mouse, Biotin
|
|
|
|
|
CD2, Rat Mab anti-Mouse, PE
|
|
|
|
|
CD5,RATMABANTI-MOUSE:CLONE:53-7.8,RATIGG2A,FITC
|
|
|
|
|
CD3,RATANTI-MOUSE
|
|
|
|
|
CD94,RATMABANTI-MOUSE:CLONE:15F.18D1,RATIGG1K,FITC
|
|
|
|
|
CD5,RATMABANTI-MOUSE:CLONE:53-7.8,RATIGG2A,BIOTIN
|
|
|
|
|
CD157,RATMABANTI-MOUSE:CLONE:KT157
|
|
|
|
|
CD226,RATMABANTI-MOUSE:CLONE:15F.10E5,RATIGMK
|
|
|
|
|
CD4,RATANTI-MOUSE
|
|
|
|
|
CD5,RATMABANTI-MOUSE:CLONE:53-7.8,RATIGG2A,PE
|
|
|
|
|
CD94,RATMABANTI-MOUSE:CLONE:15F.18D1,RATIGG1K
|
|
|
|
|
γ-CEHC AChE Tracer
|
|
|
|
|
CD45RB,LCA,CLONE:PD7/26,MABANTI-HUMAN
|
|
|
|
|
CD45RB,LCA(HIGHMW),180,190,205&220KD,EXONB,CLONE:344(BRA-11G),MABANTI-HUMAN,FITC
|
|
|
|
|
CD45RB,LCA(HIGHMW),180,190,205&220KD,EXONB,CLONE:B26.1(BRA-55),MABANTI-HUMAN,FITC
|
|
|
|
|
Cd45R/B220(Ly5),Mouse
|
|
|
|
|
CD45RB,LCA,T-CELL(NAIVE),B-CELL(MATURE),220KD,CLONE:315(DFB1),MABANTI-HUMAN
|
|
|
|
|
CD45RB,LCA,CLONE:PD7/26,MABANTI-HUMAN,FITC
|
|
|
|
|
CD45RB,LCA,CLONE:PD7/26,MABANTI-HUMAN:FROZEN/PARAFFIN
|
|
|
|
|
CD45RB,LCA(HIGHMW),180,190,205&220KD,EXONB,CLONE:B26.1(BRA-55),MABANTI-HUMAN
|
|
|
|
|
CD45RB,LCA,T-CELL(NAIVE),B-CELL(MATURE),220KD,CLONE:315(DFB1),MABANTI-HUMAN,FITC
|
|
|
|
|
CD45RB,LCA(HIGHMW),180,190,205&220KD,EXONB,CLONE:344(BRA-11G),MABANTI-HUMAN
|
|
|
|
|
CD45RC,CLONE:IBL-8,RATMABANTI-MOUSE
|
|
|
|
|
Cd45Rb,Mouse
|
|
|
|
|
γ-CEHC EIA Kit (plasma and serum)
|
|
|
|
|
γ-CEHC EIA Antiserum
|
|
|
|
|
γ-CEHC EIA Standard
|
|
|
|
Cefuzonam
|
82219-78-1
|
C16H15N7O5S4
|
|
|
CD45RC,LCA,CLONE:CLB11G1,MABANTI-RAT,DOESNOTCROSS-BLOCK
|
|
|
|
|
CD45R,CLONE:KD3,MABANTI-HUMAN
|
|
|
|
|
CD4 RECOMBINANT SOLUBLE
|
|
|
|
|
CD2, Recombinant, Human (E Rosette Receptor, T11, Lymphocyte Function Antigen 2, LFA-2)
|
|
|
|
|
CD4, Recombinant, Human
|
|
|
|
|
CD8 receptor
|
|
|
|
|
CD40 receptor-associated factor 1
|
|
|
|
|
CD30,REED-STERNBERGCELL,KI-1ANTIGEN,CLONE:KI-1,MABANTI-HUMAN
|
|
|
|
|
CD30,REED-STERNBERGCELL,KI-1ANTIGEN,CLONE:BER-H2,MABANTI-HUMAN,FITC
|
|
|
|
|
CD30,REED-STERNBERGCELL,KI-1ANTIGEN,CLONE:BER-H2,MABANTI-HUMAN
|
|
|
|
|
CD63-related antigen
|
|
|
|
Cefyl
|
105629-49-0
|
C20H26ClN5O7S2
|
|
|
CDR4 gene product
|
|
|
|
|
CefzolinSodiumSterile
|
|
|
|
CDR-H3/C2
|
|
C98H120N16O34S2
|
|
|
CD3S
|
73142-81-1
|
|